NCT02151864 LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis Status COMPLETED Phase PHASE1
NCT02151383 Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure Status TERMINATED Phase PHASE2
NCT02150213 Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 Status COMPLETED Phase PHASE2
NCT02148133 A Study to Assess the Safety and Efficacy of Eltrombopag in Japanese Subjects With Refractory, Moderate or More Severe Aplastic Anemia Status COMPLETED Phase PHASE2
NCT02144038 Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT02143635 Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt Status COMPLETED Phase PHASE1
NCT02143622 Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients Status WITHDRAWN Phase PHASE1/PHASE2
NCT02140411 Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. Status COMPLETED Phase PHASE4
NCT02137889 Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients Status TERMINATED Phase PHASE1
NCT02132130 Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss Status COMPLETED Phase PHASE1/PHASE2
NCT02130466 A Study of the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With Trametinib and Dabrafenib in Participants With Advanced Melanoma (MK-3475-022/KEYNOTE-022) Status COMPLETED Phase PHASE1/PHASE2
NCT02130024 A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients Status COMPLETED Phase PHASE4
NCT02127697 Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma Status WITHDRAWN Phase PHASE3
NCT02126904 Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept Status UNKNOWN Phase N/A
NCT02125877 Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet) Status COMPLETED Phase PHASE2
NCT02125734 Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients Status COMPLETED Phase PHASE4
NCT02125084 Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT02124772 Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations Status COMPLETED Phase PHASE1/PHASE2
NCT02123199 Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD Status COMPLETED Phase N/A